The trade rumors surrounding St. Louis Cardinals 3B Nolan Arenado had seemingly died down a bit, but a deal with the Boston ...

If an investor was to purchase shares of BSX stock at the current price level of $102.10/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Notable companies reporting before tomorrow’s open, with earnings consensus, include Disney (DIS), consensus $1.43… Boston Scientific (BSX), ...

without needing major open-heart surgery. The company believes that its Prime platform, with its enhanced features and ...

BTIG analyst Marie Thibault maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $120.00. The ...

Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

If an investor was to purchase shares of BSX stock at the current price level of $100.21/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

For the current quarter ending in March, Boston Scientific expects its per-share earnings to range from 66 cents to 68 cents. The company expects full-year earnings in the range of $2.80 to $2.87 per ...

Boston Scientific (NYSE:BSX) makes medical devices. One of their most notable achievements was the development of a special device used to open clogged arteries in the heart called “Taxus Stent.” ...